INDANAZOLINE
UNII L0U38EHD86

Substance Identification & Data

This profile provides standardized clinical and technical data for Indanazoline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L0U38EHD86.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 40507-78-6 and the RxNorm Concept ID (RxCUI) 27492. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L0U38EHD86

CAS Registry Number

40507-78-6

RxNorm Concept ID

27492

Detailed Substance Profile

Preferred Name

INDANAZOLINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H15N3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KUCWWEPJRBANHL-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C65908

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

65979

Unique identification number in the NCBI database of chemical substances.

INN ID

4733

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1c2cccc(NC3=NCCN3)c2CC1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Indanazoline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.